Stocksigma LogoStocksigma Logo

SMS Pharmaceuticals Schedules Board Meeting on 4th Nov'26 for Q2 Results

SMS Pharmaceuticals Limited announced that its Board of Directors will meet on 4th Nov'26 to consider and approve the standalone and consolidated unaudited

SMS Pharmaceuticals Schedules Board Meeting on 4th Nov'26 for Q2 Results

SMS Pharmaceuticals Ltd 路 Intimation 路 04 Nov 2026, 5:30 am

SMS Pharmaceuticals Schedules Board Meeting on 4th Nov'26 for Q2 Results SMS Pharmaceuticals Limited announced that its Board of Directors will meet on 4th Nov'26 to consider and approve the standalone and consolidated unaudited financial results for the second quarter and half year ended 30th Sep'26. Additionally, the trading window for dealing in company equity shares, which has been closed for designated persons since 1st Oct'26, will remain closed through 6th Nov'26 and reopen on 7th Nov'26 in compliance with insider trading regulations.

Original exchange filing (PDF)

More announcements from SMS Pharmaceuticals Ltd

All SMS Pharmaceuticals Ltd announcements